ATE375404T1 - Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose - Google Patents

Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose

Info

Publication number
ATE375404T1
ATE375404T1 AT01114412T AT01114412T ATE375404T1 AT E375404 T1 ATE375404 T1 AT E375404T1 AT 01114412 T AT01114412 T AT 01114412T AT 01114412 T AT01114412 T AT 01114412T AT E375404 T1 ATE375404 T1 AT E375404T1
Authority
AT
Austria
Prior art keywords
tumor
markers
blood
relative
presymptomatic
Prior art date
Application number
AT01114412T
Other languages
English (en)
Inventor
Lan Kluwe
Original Assignee
Von Recklinghausen Ges E V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Von Recklinghausen Ges E V filed Critical Von Recklinghausen Ges E V
Application granted granted Critical
Publication of ATE375404T1 publication Critical patent/ATE375404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01114412T 2000-06-27 2001-06-15 Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose ATE375404T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113607 2000-06-27

Publications (1)

Publication Number Publication Date
ATE375404T1 true ATE375404T1 (de) 2007-10-15

Family

ID=8169084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01114412T ATE375404T1 (de) 2000-06-27 2001-06-15 Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose

Country Status (4)

Country Link
US (3) US6660477B2 (de)
AT (1) ATE375404T1 (de)
DE (1) DE50113102D1 (de)
ES (1) ES2291246T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180090396A (ko) 2008-01-18 2018-08-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
WO2009149166A2 (en) * 2008-06-03 2009-12-10 Children's Hospital Medical Center Methods and compositions for the diagnosis and treatment of proliferative disorders
AU2011280944A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2965086A4 (de) 2013-03-09 2017-02-08 Harry Stylli Verfahren zum nachweis von prostatakrebs
DE102013221452B3 (de) * 2013-10-22 2015-02-26 Universitätsklinikum Hamburg-Eppendorf Verfahren zur Bestimmung der Wirksamkeit und/oder Spezifität eines Wirkstoffs
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
WO2018237088A1 (en) 2017-06-20 2018-12-27 Bio-Rad Laboratories, Inc. DIGITAL AMPLIFICATION ASSAYS FOR GENETIC INSTABILITY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605799A (en) 1990-07-12 1997-02-25 University Of Utah Research Foundation Somatic mutations in neurofibromatosis type 1 gene in human tumors
US5707863A (en) * 1993-02-25 1998-01-13 General Hospital Corporation Tumor suppressor gene merlin
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
CN1128049A (zh) * 1994-03-18 1996-07-31 犹他大学研究基金会 多肿瘤抑制因子基因种系突变及检测该基因癌肿倾向性的方法
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene

Also Published As

Publication number Publication date
ES2291246T3 (es) 2008-03-01
US20110008773A1 (en) 2011-01-13
US6660477B2 (en) 2003-12-09
US20010055770A1 (en) 2001-12-27
US20040091927A1 (en) 2004-05-13
DE50113102D1 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
Garcia et al. Effect of environmental factors on PCR-DNA analysis from dental pulp
NO972006D0 (no) Ny metode for diagnose av sykdommer
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
ATE375404T1 (de) Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose
WO2004075733A3 (en) Construction of a deafness gene chip
WO2002054187A3 (en) Collecting and managing clinical information
RU99116979A (ru) Масштабное генотипирование заболеваний и диагностический тест на мозжечковую атаксию тип 6
EP1441301A3 (de) Verfahren für das Identifizieren und das Kommunizieren mit möglichen Teilnehmern an klinischen Versuchen
Senst et al. Which tissue to take? A retrospective study of the identification success of altered human remains
WO2002090583A3 (en) Skin treatment
Nakanishi et al. Effects of environmental conditions to which nails are exposed on DNA analysis of them
Haglund et al. Identification of decomposed human remains by deoxyribonucleic acid (DNA) profiling
ATE286253T1 (de) Methoden zur diagnose oder prognose der alzheimerschen krankheit
KR102139315B1 (ko) Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커
KR102313459B1 (ko) 알츠하이머병 치매 특이적 dna 메틸레이션 마커 검출용 조성물 및 검출방법
JP2022087075A (ja) アトピー性皮膚炎の症度変化の検出方法
Biehler-Gomez et al. Frequency of biological non-skeletal materials in dry bone scenarios
WO2022186519A1 (ko) 호기 응축물 시료를 이용한 세균 메타게놈 분석 방법
JP6288758B2 (ja) 唾液の細菌叢の解析方法
Tomsia et al. Human costal cartilage, tooth cavities, and femur nutrient canals—new niches for insects used in forensic entomology
KR102313458B1 (ko) 알츠하이머병 치매 관련 유전자 바이오마커 및 이의 이용
KR102313456B1 (ko) Naa60 유전자의 후성유전학적 변화를 이용한 알츠하이머병 치매 진단
KR102313457B1 (ko) 알츠하이머병 치매 특이적 유전자 nhlrc4 및 이를 이용한 알츠하이머병 치매 예측
KR102313452B1 (ko) 알츠하이머병 치매 치료를 위한 분자 진단 테스트
Arango Apoyo social, autoestima, eventos vitales y depresion: Un estudio longitudinal en muestras colombianas.